ELAVL1 and metabolic dysfunction-associated steatotic liver disease: To further identify the potential underlying mechanisms by which hepatic deletion of HuR promotes NAFLD progression, we examined H19 expression in the livers of human NASH patients and WDSW-induced NASH mouse models.